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Abstract
Gene silencing by transient or stable RNA-interference (RNAi) is used for the study of apoptosis with an assumption that
apoptotic events will not influence RNAi. However, we recently reported that stable RNAi, i.e., a permanent gene-
knockdown mediated by shRNA-generating DNA vectors that are integrated in the genome, fails rapidly after induction of
apoptosis due to caspase-3-mediated cleavage and inactivation of the endoribonuclease Dicer-1 that is required for
conversion of shRNA to siRNA. Since apoptosis studies also increasingly employ transient RNAi models in which apoptosis is
induced immediately after a gene is temporarily knocked down within a few days of transfection with RNAi-inducing agents,
we examined the impact of apoptosis on various models of transient RNAi. We report here that unlike the stable RNAi, all
forms of transient RNAi, whether Dicer-1-independent (by 21mer dsRNA) or Dicer-1-dependent (by 27mer dsRNA or shRNA-
generating DNA vector), whether for an exogenous gene GFP or an endogenous gene poly(ADP-ribose) polymerase-1, do
not fail for 2–3 days after onset of apoptosis. Our results reflect the differences in dynamics of achieving and maintaining
RNAi during the early phase after transfection in the transient RNAi model and the late steady-state phase of gene-
knockdown in stable RNAi model. Our results also sound a cautionary note that RNAi status should be frequently validated
in the studies involving apoptosis and that while stable RNAi can be safely used for the study of early apoptotic events,
transient RNAi is more suitable for the study of both early and late apoptotic events.
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Introduction
RNA-interference (RNAi) is a mechanism for sequence-specific
silencing of a gene by 21–23mer dsRNA, also called small interfering
RNA (siRNA) which guides RNA-induced silencing complex (RISC)
containing the endoribonuclease of the Argonaut family(Ago) to search
and destroy the target mRNA [1,2]. In mammalian cells, transient
RNAi, i.e., knockdown of a target gene for a few days can be achieved
rapidly after transfection with a synthetic 21mer dsRNA or its
precursors, such as 27mer dsRNA [3] or a short hairpin RNA
(shRNA)-generating DNA vector [4]. While the transfected 21mer
dsRNA/siRNA is directly incorporated in the RISC, the 27mer
dsRNA or DNA vector-derived shRNA need to be converted first to
siRNA by the endoribonuclease Dicer-1. In transient RNAi models,
the gene expression returns to normal once siRNA or its precursors are
degraded; and the siRNA-loaded RISC molecules are depleted due to
dilution with cell division or metabolic instability in the absence of
target mRNA [1]. Stable RNAi, on the other hand, can be achieved
when shRNA-generating DNA vector is integrated in the genome
under selection pressure, so that its transcription results in a continuous
supply of shRNA molecules and stable knockdown of the target gene
[4]. Both transient and stable RNAi are being exploited in mammalian
cells for examining various cellular processes [2], and more specifically
to studyapoptosis with an assumption that these RNAiprocesses would
not be affected by apoptosis. However, recently we reported that stable
RNAi fails soon after induction of apoptosis because of caspase-
mediated cleavage and inactivation of Dicer-1, which is required to
form siRNA from DNA vector-derived shRNA [5]. However, the
impact of apoptosis on transient RNAi has never been examined
although some apoptosis studies use Dicer-1-dependent transient
RNAi achieved with 27mer dsRNA [6] or the shRNA-generating
DNA vectors [7]. Hence, we characterized apoptotic fate of Dicer-1-
dependent and independent forms of transient RNAi of an exogenous
and an endogenous gene and compared it with stable RNAi. We
report here that while Dicer-1-dependent stable RNAi rapidly fails
after onset of apoptosis, the transient RNAi, whether dependent on
Dicer-1 or not, continues to knockdown the target genes for several
days after onset of apoptosis, reflecting the differences in dynamics of
achieving RNAi in transient and stable RNAi.
Results
Persistence of transient RNAi whereas failure of stable
RNAi of stably expressed GFP
We first compared the apoptotic fate of transient and stable
RNAi of GFP which were achieved using the same shRNA-
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express high levels of GFP (CHO-GFP) (Fig. 1). For stable RNAi,
CHO-GFP cells were transfected with shGFP-234 and clones with
permanent knockdown of GFP were isolated over several weeks
after transfection. A semi-quantitative analyses of GFP signals
revealed that two of these shGFP-234 clones #62 and #64 had
stable and significant (.90%) knockdown of GFP, when compared
to GFP expression in the control CHO-GFP cells (Fig. 1A, lanes
1, 5 and 9). For transient RNAi, CHO-GFP cells were transfected
with shGFP-234 for 48 h to obtain ,60% knockdown of GFP
(Fig. 1A, lanes 13 and 16). Apoptosis was induced in both the
RNAi models by treatment with ultraviolet B (UVB) and the fate
of RNAi was monitored for further 72 h. In the CHO-GFP cells,
high levels of GFP expression present prior to induction of
apoptosis remained unchanged up to 72 h after UVB-treatment
that caused formation of activated caspase-3 (Fig. 1A, lanes 1–4).
Thus, GFP gene expression or protein stability per se are not
altered during apoptosis. In the two stable shGFP clones where the
expression of GFP was significantly knocked down prior to
apoptosis, UVB-induced apoptosis resulted in a failure of RNAi,
i.e., an increase in GFP levels by 48–72 h concomitant with
caspase-3 activation (Fig. 1A, lanes 5–12). This is in agreement
with our earlier demonstration of apoptosis-associated failure of
stable RNAi for three other genes, namely poly(ADP-ribose)
polymerase-1 (PARP), p14
ARF and lamin A/B [5]. Interestingly,
transient RNAi by the same shGFP-234, which was achieved prior
to induction of apoptosis, did not fail for up to 72 h after exposure
to UVB, because the GFP signal did not increase in the 120 h-
UVB-treated cells as compared to 120 h-untreated cells (Fig. 1A,
lanes 16-19).
To determine whether changes in GFP protein levels were
indeed due to the influence of RNAi on the availability of GFP
transcripts, the relative abundance of mRNA for GFP over control
gene GAPDH were analyzed in these two models by RT-PCR
(Fig. 1B). In the CHO-GFP cells without any RNAi, the GFP
transcript levels before and after induction of apoptosis were not
significantly altered confirming that apoptosis does not directly
influence transcription of GFP or the stability of its mRNA
(Fig. 1B, lanes 1-4). In two stable RNAi clones, the relative GFP
mRNA levels were significantly (4-66 fold) upregulated after
induction of apoptosis as compared to the levels seen prior to
apoptosis (Fig. 1B, lanes 5-8 and 9-12), indicating failure of stable
RNAi of GFP and the accumulation of its transcripts from 24 h
onwards. In contrast, in the transient RNAi model, a relatively
moderate decrease in GFP transcripts (30%) at 72 h after
transfection and prior to induction of apoptosis (Fig. 1B, lanes
13 and 15) was not significantly reversed for up to 72 h after UVB-
induced apoptosis (Fig. 1B, lanes 15 and 16), indicating the
persistence of transient RNAi during apoptosis. Thus, despite
originating from the same shGFP-234 DNA vector, the stable
RNAi of GFP rapidly failed by 24–48 h, whereas the transient
RNAi persisted up to 3 days after onset of apoptosis.
It is plausible that apoptosis-associated failure of RNAi did not
become evident in the above described transient RNAi model
simply because it started with a much lesser extent of knockdown
of GFP (60%) as compared to highly efficient (91–92%)
knockdown seen in stable RNAi model. To address this issue,
we employed a variety of transient transfection conditions, such as
use of a different shRNA-generating DNA vector (shGFP-477), a
combination of two shGFP DNA vectors or a 27mer dsRNA to
achieve much greater extent of transient GFP knockdown
(Fig. 1C). The DNA vector shGFP-477 or a combination of
shGFP-234 and shGFP-477, yielded 67 and 82% GFP-knock-
down, respectively at 72 h after transfection (Fig. 1C, lanes 1, 2
and 4). An even greater extent of knockdown (88–89%) was
achieved at 72 h after transient transfection with 5 or 20 pmol of
27mer dsRNA (Fig. 1C, lanes 1, 6 and 8). In each of these
transient RNAi models, the signal for GFP did not increase for up
to 72 h after UVB-treatment that caused formation of activated
caspase-3 (Fig. 1C, lanes 2–9: compare lanes +/2 UVB in each
set), confirming that irrespective of the extent of knockdown from
60–89%, transient RNAi did not fail for up to 3 days after onset of
apoptosis.
Persistence of GFP-knockdown during apoptosis in
stable RNAi clones supplemented with transient RNAi
As above studies examined transient and stable RNAi in
different cellular models, we next examined the apoptotic fate of
GFP-knockdown in the cells containing both stable and transient
RNAi (Fig. 2). To the shGFP-234 clone #62 that has a pre-
existing (91%) stable RNAi of GFP (Fig. 2A, lanes 1 and 2), we
added transient RNAi by transfection with GFP-targeting 21mer
dsRNA, 27mer dsRNA or shGFP-234 DNA vector, which resulted
in a total knockdown of 94–97% at 48 h after transfection
(Fig. 2A, lanes 1, 2, 3, 5 and 7). When apoptosis was induced by
UVB in these cells, it resulted in formation of activated caspase-3,
but there was no increase in GFP signal at 72 h after UVB
treatment (Fig. 2A, lanes 3–8: paired lanes +/2 UVB). Thus,
although stable RNAi failed during apoptosis (Fig. 1A), addition
of transient RNAi allowed the same cells to continue to
knockdown GFP during apoptosis. To confirm the general nature
of above observation, we used another stable clone #64 for
shGFP-234 and induced apoptosis with N-methyl-N’-nitroso-N-
nitrosoguanidine (MNNG) instead of UVB (Fig. 2B). In this
clone, the original 97% stable GFP-knockdown (Fig. 2B, lanes 1
and 3) was slightly improved (from ,1 to 2%) after addition of
transient RNAi with two different combinations of shGFP-234 and
shGFP-477 DNA vectors or 27mer dsRNA (Fig. 2B, lanes 1,3,5,7
and 9). When apoptosis was induced by MNNG in these cells, the
GFP signal increased by 36fold in the cells which had only stable
RNAi (Fig. 2B, lanes 3 and 4), confirming apoptosis-associated
abrogation of stable RNAi. However, GFP signal did not increase
in the cells which had transient RNAi added to the stable RNAi
(Fig. 2B, lanes 5–10, compare lanes +/2 MNNG), confirming
that GFP knockdown by transient RNAi continued to remain
functional in a background where stable RNAi was failing. We
also confirmed in the stable clone #64 with or without added
transient RNAi by shGFP-234 that UVB-induced apoptosis
caused a failure of RNAi in cells with stable RNAi alone but not
in the cells with stable plus transient RNAi (Supplementary Figure
S1). Thus, even in the same cell, while stable RNAi of GFP failed,
addition of transient RNAi allowed continued knockdown of GFP
during apoptosis, confirming persistence of transient RNAi during
UVB or MNNG-induced apoptosis.
Persistence of different forms of transient RNAi of co-
expressed GFP during apoptosis
While above studies examined RNAi of target gene GFP that is
stably expressed, many transient RNAi studies examine knock-
down of a co-transfected target gene; hence we examined
apoptotic fate of transient RNAi of a co-transfected GFP. In the
human skin fibroblasts, GFP-expression vector was co-transfected
with two different shGFP DNA vectors (#234 and 477) or a 21mer
dsRNA. The GFP expression at 72 h after transfection of the
GFP-expression vector alone was significantly suppressed (80–
99%) when co-transfected with all three transient RNAi-inducing
agents (Fig. 3A, 72 h lanes). At this stage, when apoptosis was
Transient RNAi in Apoptosis
PLoS ONE | www.plosone.org 2 August 2010 | Volume 5 | Issue 8 | e12263Figure 1. Failure of stable but not transient RNAi of stably expressed GFP during apoptosis in CHO-GFP cells. (A) Comparison of GFP
protein knockdown levels during stable versus transient RNAi by shGFP-234. For stable RNAi (left panel), CHO-GFP parental cells and its two stable
shGFP-234 clones #62 and 64 were treated with 1,600 J/m
2 UVB and samples were harvested from 24–72 h for immunoblotting. For transient RNAi
(right panel), CHO-GFP cells were transfected with shGFP-234 (or mock pCMV vector) for 48 h, treated with UVB and harvested from 48–72 h for
immunoblotting. Caspase-3 probing served to confirm apoptosis and actin-probing served as a loading control. GFP-levels are expressed relative to
the untreated CHO-GFP controls (lanes 1 and 13). (B) Comparison of GFP transcript levels during stable versus transient RNAi by shGFP-234. From the
cells treated as above, total RNA was extracted and subjected to RT-PCR determination of mRNA for GFP and GAPDH, the ratio of GFP/GAPDH is
expressed as relative to respective untreated control (lanes 1 and 13). For both A and B panels, experiments were repeated 3–4 times with identical
results. (C) Comparison of GFP protein knockdown levels in cells with variable extent of transient RNAi introduced by shGFP-234, shGFP-477 or 27mer
dsRNA. The CHO-GFP cells were transfected with 3 mg shGFP-477 alone or in (1:2) combination with shGFP-234, and with different concentrations of
27mer dsRNA. The control CHO-GFP cells were mock transfected with unrelated shRNA-generating DNA vector. At 72 h after transfection,
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any increase in GFP levels at 90 h (i.e., 72 h transfection plus 18 h
etoposide) over its respective 90 h non-apoptotic control in each of
the RNAi model (Fig. 3A, paired 90 h lanes +/2 etoposide),
confirming the persistence of Dicer-1-dependent and independent
mode of transient RNAi of co-transfected GFP during apoptosis.
Further analyses of these cells revealed that etoposide-treatment
caused activation of caspase-3 and cleavage of PARP to its 89 kDa
fragment, accompanied by apoptosis-specific cleavage of Dicer-1
to a 180 kDa fragment [5], whereas RISC-associated Ago-2
remained intact (Fig. 3A, lanes 2, 5, 8, 11, 15 and 18). The
presence of intact Ago-2 during apoptosis was in agreement with
the persistence of RISC-mediated transient RNAi by 21mer
dsRNA. However, despite the cleavage of Dicer-1 to its 180 kDa
fragment, which results in its catalytic inactivation [5], pre-existing
transient RNAi by the shRNA-generating DNA vector did not fail
for at least 18 h after induction of apoptosis.
To examine whether the extent of gene knockdown plays a role
in the persistence of transient RNAi during cell death, we obtained
variable extent of GFP-knockdown with increasing amounts of
Dicer-1-substrate 27mer dsRNA. The co-transfection of GFP-
expression plasmid with 0.2, 1 or 2 pmol of 27mer dsRNA caused
10, 60 or 90% GFP-knockdown, respectively at 72 h (Fig. 3B,
lanes 1, 4, 7 and 10). The induction of apoptosis with etoposide
treatment resulted in activation of caspase-3 but caused no
significant change in GFP at all three levels of GFP-knockdown
(Fig. 3B, paired 90 h lanes +/2 etoposide), indicating that
persistence of Dicer-1-dependent transient RNAi during apoptosis
was not influenced by the extent of gene-knockdown.
Persistence of different forms of transient RNAi of PARP
during apoptosis
Finally, since GFP is an exogenous gene, we examined whether
transient RNAi of an endogenous and constitutively expressed
gene PARP will also persist during apoptosis (Fig. 4). In the
human skin fibroblasts, transient RNAi of PARP with shRNA-
generating DNA vector SiP912 [8], 27mer dsRNA or 21mer
dsRNA for 72 h resulted in 60–80% PARP-knockdown as
compared to PARP-levels seen in the cells without RNAi (Fig. 4,
72 h lanes). Induction of apoptosis by 18 h treatment with
etoposide at this stage resulted in activation of caspase-3 and
cleavage of the residual PARP to its 89 kDa fragment, but no net
increase in the total amount of PARP and its 89 kDa fragment
after apoptosis in all models of transient RNAi (Fig. 4, 90 h lanes
+/2 etoposide). Etoposide treatment consistently induced cleav-
age of Dicer-1 to its 180-kDa fragment (Fig. 4, 90 h lanes),
indicating that despite cleavage of Dicer-1, transient RNAi of the
endogenous gene PARP by Dicer-1-independent (21mer dsRNA)
or Dicer-1-dependent (shRNA and 27mer dsRNA) mechanisms
persisted during apoptosis.
Discussion
We show here that transient RNAi of endogenous or exogenous
gene, which has been achieved after short-term transfection with
the gene-targeting 21mer dsRNA (siRNA), 27mer dsRNA or
shRNA-generating DNA vector, does not fail for 2–3 days after
onset of apoptosis. The results with 21mer dsRNA and detection
of intact Ago-2 during apoptosis confirm our earlier report that
Figure 2. Persistence of GFP-knockdown during apoptosis in stable RNAi cells co-expressing transient RNAi. (A) Effect of UVB-induced
apoptosis on RNAi of GFP in the stable RNAi clone #62 supplemented with transient RNAi. The shGFP-234 clone #62 with a stable RNAi of
constitutively expressed GFP was transiently transfected with one of the three GFP-targeting RNAi-inducing agents: 120 pmol of 21mer dsRNA, 2
pmol of 27mer dsRNA or 3 mg of shGFP-234 or with 3 mg of unrelated shRNA–generating DNA vector as control (mock) for transfection. At 48 h after
transfection, unirradiated cells were harvested (UVB-) and the rest were treated with 1,600 J/m
2 UVB (UVB+) and harvested after 72 h. (B) Effect of
MNNG-induced apoptosis on RNAi of GFP in the stable RNAi clone #64 supplemented with transient RNAi. The shGFP-234 clone #64 was transiently
transfected with 3 mg of shGFP-234 and shGFP-477 DNA vector (2:1 and 1:2) in combination or with 5 pmol of 27mer dsRNA for 48 h. Mock control
was transfected as mentioned above. At 48 h after transfection, untreated cells were harvested (MNNG-), while the rest were treated with 300 mM
MNNG (MNNG+) and harvested 24 h later. For both the panels, the samples were probed for GFP and activated caspase-3, whereas actin probing
served as a loading control. The experiments were repeated 4 times with identical results.
doi:10.1371/journal.pone.0012263.g002
unirradiated cells were harvested (UVB-) and the rest were treated with 1,600 J/m
2 UVB and harvested after 72 h (UVB+). The samples were probed for
GFP and activated caspase-3, whereas actin probing served as a loading control. GFP-levels are expressed relative to the untreated CHO-GFP controls
(lane 1). The experiments were repeated 4 times with identical results.
doi:10.1371/journal.pone.0012263.g001
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PLoS ONE | www.plosone.org 4 August 2010 | Volume 5 | Issue 8 | e12263Figure 3. Persistence of transient RNAi of co-transfected GFP during apoptosis in GM637 cells. For examining apoptotic fate of transient
RNAi of co-expressed GFP, GM637 cells were co-transfected with a GFP-expression vector and one of the following RNAi-inducing agents: (A) shGFP-
234, shGFP-477 and 21mer dsRNA or mock pCMV vector; or (B) Varying amounts (0, 0.2, 1.0 and 2.0 pmol) of 27mer dsRNA. At 72 h of knockdown,
apoptosis was induced by treatment with 100 mM etoposide (or mock-control) for 18 h. Samples were harvested at 72 h (before apoptosis) or 90 h
(after apoptosis) for immunoblotting for GFP, Dicer-1, Ago-2, activated caspase-3 and PARP, as specified for each panel. The relative GFP values were
determined as described in Fig. 1A. For above panels, either Ponceau-S staining or actin immunoprobing served as loading controls and Ap refers to
apoptotic cell extract prepared from etoposide-treated HL-60 cells. The experiments were repeated at least four times with identical results.
doi:10.1371/journal.pone.0012263.g003
Transient RNAi in Apoptosis
PLoS ONE | www.plosone.org 5 August 2010 | Volume 5 | Issue 8 | e12263RISC/Ago-2-mediated transient RNAi continues to function
normally during apoptosis [5]. However, our results showing the
persistence of transient RNAi by Dicer-1-dependent 27mer
dsRNA or shRNA for up to 2–3 days during apoptosis is in
contrast to the rapid failure of shRNA-mediated stable RNAi,
which was reported earlier [5] and confirmed here. Since
apoptotic cleavage of Dicer-1 to 180 kDa fragment results in its
catalytic inactivation [5], it is evident that the production of new
siRNA molecules from its precursors by the action of Dicer-1
would be halted with the onset of apoptosis in both the models of
RNAi. However, this seems to interrupt only the stable RNAi and
not the transient RNAi, indicating that the dynamics of achieving
gene-knockdown and the dependency on Dicer-1 function must be
different in stable and transient RNAi.
At least four factors could be responsible for the difference in the
response of transient versus stable RNAi during apoptosis: (i)
stability of siRNA-loaded RISC molecules; (ii) availability of
siRNA in the cells at the time of onset of apoptosis; (iii) the half-life
of siRNA; and (iv) the optimum number of siRNA-loaded RISC
molecules required for an efficient gene knockdown. It has been
suggested that siRNA-loaded RISC may be very stable [1], which
could readily explain the persistence of all forms of transient RNAi
during apoptosis, because once formed prior to onset of apoptosis,
the siRNA-loaded RISC molecules could continue to knockdown
the gene for several more days or until the cell dies by apoptosis.
However, this does not explain why stable RNAi which also has an
efficient (.90%) gene knockdown by siRNA-loaded RISC prior to
induction of apoptosis, fails after onset of apoptosis. Our results
with stable RNAi strongly indicate that siRNA-loaded RISC
cannot be very stable, and that input of siRNA at regular intervals
is required for the RISC to continue to knockdown a gene; thus
making it potentially susceptible to interruption in the supply of
siRNA due to cleavage/inactivation of Dicer-1. Thus, an RNAi
model in which the cells have higher supply of siRNA at the time
of onset of apoptosis is likely to persist for a few days during
apoptosis, whereas one with a minimal steady-state supply of
siRNA is likely to be abrogated rapidly due to rapid exhaustion of
its siRNA. In the transient RNAi, since there is a massive influx of
siRNA or its precursor (27mer dsRNA or shRNA-generating
DNA), a large presence of preformed or Dicer-1-generated siRNA
can be expected to remain in the cells for a few more days during
which apoptosis is induced in this model. In contrast, the stable
RNAi clones are isolated over several weeks after initial
transfection; hence these cells would have lost all of the initially
transfected free shRNA-generating DNA molecules. Hence, stable
RNAi would become totally dependent on the steady-state
synthesis of shRNA from the shRNA-generating DNA integrated
in the genome.
The second most important issue after availability of siRNA at
the onset of apoptosis would be the half-life of the siRNA in cells.
In blood, siRNA has been reported to have half-life of few
minutes [1], however a recent study showed that siRNA can have
a considerably longer half-life of up to 96 h in some cells [9]. Our
results showing persistence of transient RNAi for several days
after failure of Dicer-1 supports the argument that siRNA
available at the onset of apoptosis must have sufficiently long half-
life to persist for several days and support the RISC-mediated
knockdown of the gene. In contrast, the stable RNAi clones
appear to be rapidly exhausted of the siRNA, indicating a much
lower steady-state levels of siRNA. Our data that additional
transient RNAi can be introduced in the clones with stable RNAi
(Fig. 2) supports the argument that stable RNAi clones do not
Figure 4. Persistence of transient RNAi of endogenous gene PARP during apoptosis in GM637 cells. The GM637 cells were transiently
transfected with three RNAi-inducing agents: shRNA-generating DNA vector-SiP912, 27mer dsRNA or 21mer dsRNA or mock pCMV vector as control.
At 72 h after transfection, cells were treated with 100 mM etoposide or with solvent control for 18 h and samples were harvested for immunoblotting
for PARP, activated caspase-3, Dicer-1 and Ago-2. The actin probing served as loading controls and Ap refers to apoptotic cell extract prepared from
etoposide-treated HL-60 cells. The (PARP+89-kDa) signals from each sample are expressed as relative to untreated control in lane 1. The results shown
in all three above panels are representative of 3–5 independent experiments with identical results.
doi:10.1371/journal.pone.0012263.g004
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RISC molecules. In addition, based on microRNA data, it has
been estimated that about 1000 siRNA molecules per cell can
efficiently silence a gene [1], and this number of siRNA would be
readily available for several days after onset of apoptosis in the
transient RNAi model as stated above. In contrast, since siRNA
and miRNA share the same RISC machinery in mammalian
cells, a thriving stable RNAi clone would make just the sufficient
quantity of shRNA to efficiently silence the gene while leaving the
remaining RISC molecules available for important cellular
functions by miRNA. Thus stable RNAi, operating with just
the minimally required number of siRNA-loaded RISC mole-
cules, would be more prone than transient RNAi to the apoptotic
inactivation of Dicer-1 and interruption in the supply of fresh
siRNA.
In conclusion, our results sound a cautionary note that while
using RNAi in the study of apoptosis, one must monitor and
account for a possible failure of RNAi after onset of apoptosis. Our
results validate the use of stable RNAi mainly for the study of early
apoptotic events and transient RNAi for study of both early and
late apoptotic events. Our results indicate that siRNA loaded
RISC is not very stable because it needs frequent input of fresh
siRNA and cellular siRNA formed or introduced in the cells
during transient RNAi is more stable than in blood. Thus 21mer
and 27mer siRNA have a good therapeutic potential provided
their stability could be increased in blood, because once inside the
cells, they can achieve knockdown of the target gene for a long
period of time.
Materials and Methods
Cells
The human diploid SV-40 transformed skin fibroblast cells
GM00637 (Coriell Cell Repository, Camden, NJ) and hamster cell
line CHO (sub-line WT-5) were cultured in aMEM (Gibco)
supplemented with 10% foetal bovine serum, 50 U/ml penicillin
and 50 mg/ml streptomycin at 37uC in a humidified incubator
with 5% CO2.
Creation of CHO-derived clones with stable expression of
GFP (CHO-GFP) and stable shRNA-mediated RNAi of GFP
(CHO-shGFP)
The details of creation of CHO-GFP clones and its stable RNAi
clones are provided in Methods S1. In brief, CHO cells were
transfected with pEGFP-N1 (Clontech) and strong GFP-expressing
clones were selected, one of which was used in the present study.
For stable RNAi of GFP, CHO-GFP clone was transfected with
pBS-U6-based [8] and shRNA-generating DNA vector shGFP-
234 along with pTK-Hyg plasmid to isolate stable hygromycin-
resistant shGFP clones, two of which were used in the study. The
extent of knockdown of GFP was measured relative to the GFP
levels expressed in untreated CHO-GFP control cells.
Transient RNAi of GFP or PARP
The details of all transient transfection conditions are provided
in Methods S1. In brief, for the transient RNAi of constitutively
expressed GFP, CHO-GFP cells were transfected with GFP-
targeting DNA vectors shGFP-234, shGFP-477 or 27mer dsRNA
for 48–72 h prior to induction of apoptosis. For introduction of
transient RNAi in the cells with stable RNAi of GFP, the shGFP-
234-clone #62 or clone #64 were transfected with GFP-targeting
21mer dsRNA, 27mer dsRNA, shGFP-234 or shGFP-477 DNA
vector for 48 h prior to induction of apoptosis. The mock control
cells were transfected with equivalent amount of blank vector
pCMV DNA or unrelated shRNA-generating DNA vector. For
transient RNAi of co-expressed GFP, GM637 cells were
transfected with pEGFP-N1 (Clontech) cDNA or CMV plasmid
(as mock DNA) with or without GFP-targeting 21mer dsRNA,
27mer dsRNA, shGFP-234 or shGFP-477. For transient RNAi of
PARP, GM637 cells were transfected with one of the following
PARP-targeting 21mer dsRNA, 27mer dsRNA (IDT) or shRNA-
directing SiP912 DNA vector [8].
Apoptosis-inducing treatments and Western blotting
Apoptosis was induced in different models with either 1,600 J/
m
2 UVB (Spectrolinker XL-1000 UV cross-linker), 300 mM
MNNG or 100 mM etoposide for specified time. The cell extracts
were prepared and samples representing 200,000 cells or 10–
20 mg protein were resolved on 6, 8 or 12% SDS-PAGE, blotted
on nitrocellulose and probed with following antibodies: GFP
(Roche, 1:5,000); PARP (C-2-10, Aparptosis Inc., 1:10,000);
human Dicer-1 (Abcam, 1:1,000); human Ago-2 (Wako, 1:200);
activated caspase-3 (Cell Signaling, 1:1,000) and Actin (Sigma,
1:20,000). The immunoblots were either read directly for
chemiluminescence or autoradiographic films were scanned using
ChemiGenius 2 Bio Imaging system (SynGene) and quantifica-
tion of signals was carried out using GeneTools software version
4.00 (SynGene).
Extraction of total RNA and RT-PCR
The details of RNA preparation, RT-PCR primers and cycle
conditions as well as data analyses are provided in Methods S1. In
brief, total RNA was prepared from 1–3610
6 cells using
mirVana
TM PARIS
TM kit (Ambion). The RT-PCR was carried
out using OneStep RT-PCR kit (Qiagen) and the MasterCycler
Personal PCR-machine (Eppendorf Life Science). The GFP or
GAPDH bands after resolution on 1.5% agarose gel were
quantified using ChemiGenius 2 with GeneTools software
(SynGene).
Supporting Information
Figure S1 Abrogation of stable RNAi but persistence of
transient RNAi in same cells during UVB-induced apoptosis.
The shGFP-234 clone #64 was transiently transfected with 3 mg
of shGFP-234 DNA vector for 48 h. The CHO-GFP parental cells
and shGFP-234 cells with or without additional transient RNAi by
shGFP-234 or unrelated shRNA-generating DNA vector (control)
were treated either with 1,600 J/m
2 UVB or mock-irradiated. The
samples were harvested at 72 h and probed for GFP and activated
caspase-3, whereas actin probing served as a loading control. The
experiments were repeated 3 times with identical results. GFP-
levels are expressed relative to the untreated CHO-GFP controls
(lane1).
Found at: doi:10.1371/journal.pone.0012263.s001 (0.56 MB
TIF)
Methods S1 Detailed methods for creation of clones, transfec-
tions and RT-PCR.
Found at: doi:10.1371/journal.pone.0012263.s002 (0.04 MB
DOC)
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